PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+2.15%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$843M
AUM Growth
+$843M
(+12%)
Cap. Flow
+$124M
Cap. Flow
% of AUM
14.72%
Top 10 Holdings %
Top 10 Hldgs %
33.86%
Holding
109
New
20
Increased
44
Reduced
26
Closed
18
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$22.7M |
| 2 |
CVS Health
CVS
|
$21.5M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$19.6M |
| 4 |
UnitedHealth
UNH
|
$15.8M |
| 5 |
Revvity
RVTY
|
$14.8M |
Top Sells
| 1 |
VRNA
Verona Pharma
VRNA
|
$29.2M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$20.3M |
| 3 |
Abbott
ABT
|
$20M |
| 4 |
Gilead Sciences
GILD
|
$17.5M |
| 5 |
Boston Scientific
BSX
|
$11.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Rapid Micro Biosystems
RPID
$105M
| $1.94M | 0.23% |
+735,621
| New | +$1.94M |
|
77
Vera Therapeutics
VERA
$1.47B
| $1.83M | 0.22% |
+76,125
| New | +$1.83M |
|
78
Apogee Therapeutics
APGE
$2.27B
| $1.74M | 0.21% |
46,663
-38,337
| -45% | -$1.43M |
|
|
ICAD
79
DELISTED
iCAD Inc
ICAD
| $1.61M | 0.19% |
+781,670
| New | +$1.61M |
|
80
Maravai LifeSciences
MRVI
$341M
| $1.46M | 0.17% |
660,000
+310,000
| +89% | +$685K |
|
|
UPB
81
Upstream Bio, Inc. Common Stock
UPB
$1.08B
| $1.43M | 0.17% |
+233,563
| New | +$1.43M |
|
82
Merus
MRUS
$5.04B
| $1.19M | 0.14% |
28,230
-17,450
| -38% | -$734K |
|
|
SLN
83
Silence Therapeutics
SLN
$237M
| $1.13M | 0.13% |
401,746
-89,334
| -18% | -$252K |
|
84
Oric Pharmaceuticals
ORIC
$1.03B
| $1.13M | 0.13% |
+203,006
| New | +$1.13M |
|
85
Ardelyx
ARDX
$1.57B
| $1.03M | 0.12% |
209,581
+31,787
| +18% | +$156K |
|
86
Entera Bio
ENTX
$92.7M
| $747K | 0.09% |
439,632
+25,900
| +6% | +$44K |
|
87
Annexon
ANNX
$225M
| $678K | 0.08% |
351,436
+20,587
| +6% | +$39.7K |
|
88
Relay Therapeutics
RLAY
$709M
| $493K | 0.06% |
188,052
-312,496
| -62% | -$819K |
|
89
VYNE Therapeutics
VYNE
$8.09M
| $344K | 0.04% |
217,978
+65,005
| +42% | +$103K |
|
|
EDAP
90
EDAP TMS
EDAP
$103M
| $303K | 0.04% |
154,832
| – | – |
|
91
Ironwood Pharmaceuticals
IRWD
$201M
| $301K | 0.04% |
205,086
-203,449
| -50% | -$299K |
|
|
92
Abbott
ABT
$230B
| – | – |
-176,994
| Closed | -$20M |
|
93
Arvinas
ARVN
$580M
| – | – |
-106,871
| Closed | -$2.05M |
|
|
BCYC
94
Bicycle Therapeutics
BCYC
$492M
| – | – |
-352,481
| Closed | -$4.93M |
|
95
Butterfly Network
BFLY
$378M
| – | – |
-750,000
| Closed | -$2.34M |
|
96
Eton Pharmaceutcials
ETON
$468M
| – | – |
-276,890
| Closed | -$3.69M |
|
97
Icon
ICLR
$14B
| – | – |
-15,874
| Closed | -$3.33M |
|
98
Jazz Pharmaceuticals
JAZZ
$7.99B
| – | – |
-37,751
| Closed | -$4.65M |
|
99
Lifestance Health
LFST
$2.14B
| – | – |
-277,471
| Closed | -$2.04M |
|
100
MoonLake Immunotherapeutics
MLTX
$3.78B
| – | – |
-54,294
| Closed | -$2.94M |
|